Live Breaking News & Updates on Byondis Chief Medical Officer Jan Schellens|Page 2

Stay updated with breaking news from Byondis chief medical officer jan schellens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA to Review [Vic-]Trastuzumab Duocarmazine for HER2-Positive BRCA

The FDA has accepted the BLA for [vic-]trastuzumab duocarmazine to treat HER2-positive unresectable locally advanced or metastatic breast cancer. ....

Jan Schellens , Drug Administration , Biologics License Application , Byondis Chief Medical Officer Jan Schellens , Prescription Drug User Fee Act ,